12th Edition — S Gastrointestinal And Liver Disease
12th edition of Sleisenger and Fordtran’s Gastrointestinal and Liver Disease
(published December 2025) remains the gold-standard reference for gastroenterology and hepatology. Led by a new senior editorial team including Drs. Raymond T. Chung, David T. Rubin, and C. Mel Wilcox, this two-volume set integrates basic science with the latest clinical technologies and treatments. Core Themes and New Chapters
The 12th edition introduces specific chapters that address contemporary global health challenges and evolving scientific understanding:
Gastrointestinal and Hepatic Manifestations of Coronavirus Infection
: A new chapter dedicated to the long-term and acute impacts of COVID-19 on the digestive system. Cancer Immunotherapy Side Effects
: A new chapter on Enterocolitis and Hepatitis induced by cancer immunotherapy, reflecting the rise of biological treatments in oncology. Microbiota and Probiotics s gastrointestinal and liver disease 12th edition
: Expanded focus on the enteric microbiota, fecal microbiota transplantation, and the role of the gut-brain axis in disease. Artificial Intelligence (AI)
: New discussions on using AI in endoscopy to enhance the detection of gastrointestinal cancers. Major Clinical Updates Liver Disease Nomenclature : Transition to the term
(metabolic dysfunction-associated steatotic liver disease), formerly known as non-alcoholic fatty liver disease (NAFLD). Advanced Hepatology
: Detailed updates on the treatment of viral hepatitis, autoimmune liver diseases, and the management of cirrhosis complications. Inflammatory Bowel Disease (IBD)
: Extensive new data on biologics and novel small molecules for treating and preventing IBD recurrences. Obesity Management Why It Remains the "Gold Standard" Unlike many
: Updated sections on the surgical and endoscopic treatment of obesity, reflecting the shift toward minimally invasive interventions. Structure and Educational Features Templated Format
: Organized into 11 sections and 132 chapters for consistent, quick information retrieval. Visual Aids
: Contains more than 1,100 full-color illustrations and dozens of procedural videos accessible via the Elsevier Expert Consult eBook Clinical Algorithms
: High-speed scannable decision-making tools that summarize patient management for complex GI cases. specific summary of one of the new clinical topics like MASLD?
This is for informational purposes only. For medical advice or diagnosis, consult a professional. AI responses may include mistakes. Learn more Fecal microbiota transplantation (FMT) beyond C
Sleisenger and Fordtran's Gastrointestinal and Liver Disease
Why It Remains the "Gold Standard"
Unlike many review books that condense information into bullet points, Sleisenger and Fordtran offers depth. It does not merely state guidelines (e.g., "Administer drug X for condition Y"); it explains the pharmacokinetics, the clinical trial data behind the guideline, and the potential complications.
This edition is particularly praised for its balanced approach to evidence-based medicine. Where evidence is strong, the text is directive. Where evidence is lacking or controversial, the authors present the data neutrally, allowing the clinician to make informed decisions.
4. The Microbiome: From Science to Clinical Application
While previous editions touched on the microbiome, the 12th edition dedicates multiple chapters to its translational impact. You will learn about:
- Fecal microbiota transplantation (FMT) beyond C. difficile (e.g., for ulcerative colitis, hepatic encephalopathy).
- Probiotics, prebiotics, and postbiotics: evidence-based recommendations (and deconstruction of marketing hype).
- The role of specific microbial signatures in predicting response to immunotherapy in hepatocellular carcinoma.
Comparison: 12th Edition vs. 11th Edition vs. Other GI Textbooks
| Feature | Sleisenger 12th | Yamada’s Textbook of Gastroenterology | Current Diagnosis & Treatment: Gastroenterology | | :--- | :--- | :--- | :--- | | Pages | ~2,800 | ~2,400 | ~800 | | Online access | Yes (videos + image library) | Yes | Limited | | Focus | Comprehensive, clinically oriented | Basic science + clinical | Quick reference, concise | | Publication year | 2024 (anticipated/current) | 2022 | 2023 | | Best for | Board prep, deep dives, specialist practice | Academic researchers | Residents, busy clinicians |
Verdict: Yamada’s offers more basic science depth; Current Diagnosis is a "rapid consult." But Sleisenger and Fordtran’s 12th Edition remains the most balanced, clinically actionable textbook for the specialist.